Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Article
PubMed
Google Scholar
Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol. 2016;34(15):1787–94. https://doi.org/10.1200/JCO.2015.64.7412.
Article
CAS
PubMed
PubMed Central
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551.
Article
PubMed
Google Scholar
Tang X, Allain JP, Wang H, Rong X, Chen J, Huang K, et al. Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide. J Viral Hepat. 2018;25(9):1008–16. https://doi.org/10.1111/jvh.12901.
Article
CAS
PubMed
Google Scholar
Whitford K, Liu B, Micallef J, Yin JK, Macartney K, Van Damme P, et al. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bull World Health Organ. 2018;96(7):484–97. https://doi.org/10.2471/BLT.17.205153.
Article
PubMed
PubMed Central
Google Scholar
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54. https://doi.org/10.3322/caac.21440.
Article
PubMed
Google Scholar
Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015;62(5):1353–63. https://doi.org/10.1002/hep.27978.
Article
CAS
PubMed
Google Scholar
Jemal A, Fedewa SA. Recent hepatitis C virus testing patterns among baby boomers. Am J Prev Med. 2017;53(1):e31–3. https://doi.org/10.1016/j.amepre.2017.01.033.
Article
PubMed
Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50. https://doi.org/10.1002/hep.29913.
Article
PubMed
Google Scholar
European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L: EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
Article
Google Scholar
Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2017;6(6):387–96. https://doi.org/10.21037/hbsn.2017.11.01.
Article
PubMed
PubMed Central
Google Scholar
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22. https://doi.org/10.1007/s00432-004-0552-0.
Article
PubMed
Google Scholar
Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624. https://doi.org/10.1371/journal.pmed.1001624.
Article
PubMed
PubMed Central
Google Scholar
Singal AG, Mittal S, Yerokun OA, Ahn C, Marrero JA, Yopp AC, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med. 2017;130(9):1099–106 e1091. https://doi.org/10.1016/j.amjmed.2017.01.021.
Article
PubMed
Google Scholar
Kansagara D, Papak J, Pasha AS, O'Neil M, Freeman M, Relevo R, et al. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Ann Intern Med. 2014;161(4):261–9. https://doi.org/10.7326/M14-0558.
Article
PubMed
Google Scholar
Liver (Hepatocellular) Cancer Screening (PDQ(R)): Health Professional Version. In: PDQ Cancer Information Summaries. edn. Bethesda (MD); 2002.
Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance. Curr Probl Cancer. 2012;36(4):183–90. https://doi.org/10.1016/j.currproblcancer.2012.03.007.
Article
PubMed
Google Scholar
El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39(3):798–803. https://doi.org/10.1002/hep.20096.
Article
PubMed
Google Scholar
Surveillance, Epidemiology, And end results (SEER) program (www.seer.cancer.gov) SEER*stat database: incidence - SEER 18 Regs research data + hurricane Katrina impacted Louisiana cases, Nov 2018 sub (1975-2016 varying) - linked to county attributes - Total U.S., 1969-2017 counties, National Cancer Institute, DCCPS, Surveillance research program, released April 2019, based on the November 2018 submission. In.
Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014;272(3):635–54. https://doi.org/10.1148/radiol.14132361.
Article
PubMed
Google Scholar
Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009;23(3):288–95.
Google Scholar
Llovet JM, Fuster J, Bruix J. Barcelona-clinic liver Cancer G: the Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S115–20. https://doi.org/10.1002/lt.20034.
Article
PubMed
Google Scholar
Puigvehi M, Hashim D, Haber PK, Dinani A, Schiano TD, Asgharpour A, et al. Liver transplant for hepatocellular carcinoma in the United States: evolving trends over the last three decades. Am J Transplant. 2020;20(1):220–30. https://doi.org/10.1111/ajt.15576.
Article
PubMed
Google Scholar
Massarweh NN, Park JO, Farjah F, Yeung RS, Symons RG, Vaughan TL, et al. Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg. 2010;210(4):441–8. https://doi.org/10.1016/j.jamcollsurg.2009.12.026.
Article
PubMed
PubMed Central
Google Scholar
Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57(4):794–802. https://doi.org/10.1016/j.jhep.2012.05.007.
Article
PubMed
Google Scholar
Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3cm in potentially transplantable patients. J Hepatol. 2019;70(5):866–73. https://doi.org/10.1016/j.jhep.2018.12.027.
Article
PubMed
Google Scholar
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429–42. https://doi.org/10.1053/jhep.2003.50047.
Article
CAS
PubMed
Google Scholar
Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, Feng S, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008;48(3):819–27. https://doi.org/10.1002/hep.22412.
Article
PubMed
Google Scholar
El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60(5):1767–75. https://doi.org/10.1002/hep.27222.
Article
PubMed
Google Scholar
Doycheva I, Issa D, Watt KD, Lopez R, Rifai G, Alkhouri N. Nonalcoholic steatohepatitis is the Most rapidly increasing indication for liver transplantation in young adults in the United States. J Clin Gastroenterol. 2018;52(4):339–46. https://doi.org/10.1097/MCG.0000000000000925.
Article
PubMed
Google Scholar
Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology. 2012;55(6):1809–19. https://doi.org/10.1002/hep.25536.
Article
PubMed
Google Scholar
Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology. 2016;63(3):827–38. https://doi.org/10.1002/hep.28368.
Article
PubMed
Google Scholar
Singal AG, Yopp A, C SS, Packer M, Lee WM, Tiro JA. utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med. 2012;27(7):861–7. https://doi.org/10.1007/s11606-011-1952-x.
Article
PubMed
PubMed Central
Google Scholar
Tran SA, Le A, Zhao C, Hoang J, Yasukawa LA, Weber S, et al. Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis. BMJ Open Gastroenterol. 2018;5(1):e000192. https://doi.org/10.1136/bmjgast-2017-000192.
Article
PubMed
PubMed Central
Google Scholar
Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, et al. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol. 2016;113(1):89–93. https://doi.org/10.1002/jso.24099.
Article
PubMed
Google Scholar
Zhang W, Wang X, Huang R, Jin K, Zhangyuan G, Yu W, et al. Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma. Sci Rep. 2017;7(1):41695. https://doi.org/10.1038/srep41695.
Article
CAS
PubMed
PubMed Central
Google Scholar
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38. https://doi.org/10.1055/s-2007-1007122.
Article
CAS
PubMed
Google Scholar
Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, et al. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, epidemiology, and end results analysis. Cancer. 2014;120(23):3707–16. https://doi.org/10.1002/cncr.28912.
Article
PubMed
Google Scholar
Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int. 2009;29(4):502–10. https://doi.org/10.1111/j.1478-3231.2008.01957.x.
Article
PubMed
PubMed Central
Google Scholar
Kluger MD, Salceda JA, Laurent A, Tayar C, Duvoux C, Decaens T, et al. Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. J Hepatol. 2015;62(5):1131–40. https://doi.org/10.1016/j.jhep.2014.12.018.
Article
PubMed
Google Scholar
Zhang H, Yuan SX, Dai SY, Zhang JM, Huang X, Lu CD, et al. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion. World J Surg. 2014;38(4):947–57. https://doi.org/10.1007/s00268-013-2365-2.
Article
PubMed
Google Scholar
Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: current status and future perspectives. World J Hepatol. 2015;7(3):406–24. https://doi.org/10.4254/wjh.v7.i3.406.
Article
PubMed
PubMed Central
Google Scholar
Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC Cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845–7. https://doi.org/10.1245/s10434-017-6025-x.
Article
PubMed
Google Scholar
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696–9. https://doi.org/10.1016/0168-8278(95)80226-6.
Article
CAS
PubMed
Google Scholar
Ma WJ, Wang HY, Teng LS. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J Surg Oncol. 2013;11(1):212. https://doi.org/10.1186/1477-7819-11-212.
Article
PubMed
PubMed Central
Google Scholar